Biosimilars and Follow-On Biologics Market Opportunities 2025-2033

Ajouter une nouvelle offre d'emploi Health

2025-08-21 09:15:33 -

According to FutureWise analysis, the market for biosimilars and follow-on biologics in 2023 is US$26.03 billion, and is expected to reach US$83.69 billion by 2031 at a CAGR of 15.70%. Biosimilars are biological products designed to be highly similar to an already approved (licensed) drug, known as the reference product, as determined by regulatory authorities such as the Food and Drug...

0 Commentaires 0 Parts 460 Vue 0 Aperçu